Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.18%
#3 CoW Protocol CoW Protocol +41.66%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +26.25%
#6 Walrus Walrus +23.99%
#7 Codatta Codatta +19.58%
#8 Enso Enso +18.84%
#9 The Black Bull The Black Bull +15.34%
#10 Collector Crypt Collector Crypt +13.90%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Colinz Laboratories Limited Colinz Laboratories Limited

Colinz Laboratories Limited

COLINZ
Clasificación en acciones #36906
Colinz Laboratories Ltd. specializes in producing a diverse range of... Colinz Laboratories Ltd. specializes in producing a diverse range of pharmaceutical formulations, available in various dosage forms such as tablets, capsules, granules, oral liquids, injectables, ointments, and creams. The company's offerings target therapeutic areas including gynecology, cardiology, and gastroenterology, and span product categories like allopathy, ayurvedics, and nutraceuticals. Established on October 6, 1986, Colinz Laboratories is based in Mumbai, India.
Precio por acción
$0.88143552
Última sincronización: 2026-08-14
Capitalización bursátil
$2.22M
Cambio (1 día)
-4.06%
Cambio (1 año)
78.59%
País
IN
Comercio Colinz Laboratories Limited (COLINZ)

Categoría

Healthcare
Ganancias de Colinz Laboratories Limited (COLINZ)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Colinz Laboratories Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Colinz Laboratories Limited desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US